Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Clinical Pharmacology and Therapeutics
|
February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity
F Sata, A Sapone, G Elizondo, et al.
The Pharmacogenomics Journal
|
October 10, 2007
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach
M Rahnasto, C Wittekindt, R O Juvonen, et al.
Biochemical Pharmacology
|
November 1, 1988
Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital
H Raunio, A Kojo, R Juvonen, et al.
Carcinogenesis
|
February 1, 1997
Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells
J Hakkola, M Pasanen, O Pelkonen, et al.
International Journal of Cancer
|
May 8, 2000
Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers
R Piipari, K Savela, T Nurminen, et al.
FEBS Letters
|
November 25, 1998
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
M Oscarson, H Gullstén, A Rautio, et al.
American Journal of Human Genetics
|
September 1, 1995
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
P Fernandez-Salguero, S M Hoffman, S Cholerton, et al.
Pharmacogenetics
|
June 1, 1997
CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis
H Gullstén, J A Agúndez, J Benítez, et al.
FEBS Letters
|
April 27, 1999
Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
M Oscarson, R A McLellan, H Gullstén, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Clinical Pharmacology and Therapeutics
|
February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity
F Sata, A Sapone, G Elizondo, et al.
The Pharmacogenomics Journal
|
October 10, 2007
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach
M Rahnasto, C Wittekindt, R O Juvonen, et al.
Biochemical Pharmacology
|
November 1, 1988
Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital
H Raunio, A Kojo, R Juvonen, et al.
Carcinogenesis
|
February 1, 1997
Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells
J Hakkola, M Pasanen, O Pelkonen, et al.
International Journal of Cancer
|
May 8, 2000
Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers
R Piipari, K Savela, T Nurminen, et al.
FEBS Letters
|
November 25, 1998
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
M Oscarson, H Gullstén, A Rautio, et al.
American Journal of Human Genetics
|
September 1, 1995
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
P Fernandez-Salguero, S M Hoffman, S Cholerton, et al.
Pharmacogenetics
|
June 1, 1997
CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis
H Gullstén, J A Agúndez, J Benítez, et al.
FEBS Letters
|
April 27, 1999
Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
M Oscarson, R A McLellan, H Gullstén, et al.
Page
of 12